SOA Wealth Advisors’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.4K | Buy |
845
+605
| +252% | +$23.2K | 0.01% | 430 |
|
|
2025
Q1 | $9.31K | Sell |
240
-160
| -40% | -$6.2K | ﹤0.01% | 567 |
|
|
2024
Q4 | $13.5K | Sell |
400
-51
| -11% | -$1.72K | ﹤0.01% | 515 |
|
|
2024
Q3 | $18.5K | Sell |
451
-287
| -39% | -$11.7K | ﹤0.01% | 458 |
|
|
2024
Q2 | $28.4K | Sell |
738
-904
| -55% | -$34.8K | 0.01% | 384 |
|
|
2024
Q1 | $70.4K | Sell |
1,642
-633
| -28% | -$27.1K | 0.01% | 272 |
|
|
2023
Q4 | $84.3K | Hold |
2,275
| – | – | 0.02% | 251 |
|
|
2023
Q3 | $82.5K | Hold |
2,275
| – | – | 0.02% | 244 |
|
|
2023
Q2 | $81.1K | Buy |
2,275
+492
| +28% | +$17.5K | 0.02% | 250 |
|
|
2023
Q1 | $63.4K | Hold |
1,783
| – | – | 0.02% | 262 |
|
|
2022
Q4 | $62.7K | Hold |
1,783
| – | – | 0.02% | 255 |
|
|
2022
Q3 | $52K | Sell |
1,783
-91
| -5% | -$2.65K | 0.02% | 260 |
|
|
2022
Q2 | $101K | Buy |
1,874
+516
| +38% | +$27.8K | 0.03% | 203 |
|
|
2022
Q1 | $74K | Buy |
1,358
+10
| +0.7% | +$545 | 0.02% | 263 |
|
|
2021
Q4 | $74K | Buy |
1,348
+13
| +1% | +$714 | 0.02% | 256 |
|
|
2021
Q3 | $63K | Buy |
1,335
+12
| +0.9% | +$566 | 0.02% | 279 |
|
|
2021
Q2 | $65K | Buy |
1,323
+200
| +18% | +$9.83K | 0.02% | 274 |
|
|
2021
Q1 | $50K | Hold |
1,123
| – | – | 0.01% | 270 |
|
|
2020
Q4 | $49K | Buy |
+1,123
| New | +$49K | 0.01% | 267 |
|